Clik here to view.
Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization
WEDNESDAY, July 10, 2024 (HealthDay News) — Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants,...
View ArticleClik here to view.
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in Acne
WEDNESDAY, July 10, 2024 (HealthDay News) — Adherence to a Mediterranean diet incorporating eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces skin lesions and improves quality of life...
View ArticleClik here to view.
Air Pollutant Exposure Linked to Increased Risk for Incident Lupus
WEDNESDAY, July 10, 2024 (HealthDay News) — Air pollutant exposure is associated with an increased likelihood of developing incident systemic lupus erythematosus (SLE), according to a study published...
View ArticleClik here to view.
Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual...
WEDNESDAY, July 10, 2024 (HealthDay News) — Incentivizing smoking cessation increases smoking cessation through 12 weeks, but not at 26 weeks, when missing data are treated as smoking, according to a...
View ArticleClik here to view.
Transvaginal Ultrasound Triage Strategy for Endometrial Cancer Not Reliable...
WEDNESDAY, July 10, 2024 (HealthDay News) — For Black adults at risk for endometrial cancer (EC), a transvaginal ultrasonography triage strategy is not reliable, according to a study published online...
View ArticleClik here to view.
Rates of Gender-Affirming Surgery Examined in Cisgender Males, Gender-Diverse
WEDNESDAY, July 10, 2024 (HealthDay News) — For adults and minors, most breast reductions performed on cisgender males and transgender and gender-diverse (TGD) people are performed on cisgender males,...
View ArticleClik here to view.
Routine ECG Screening May Help to Prevent CVD Events in Adults
WEDNESDAY, July 10, 2024 (HealthDay News) — Routine electrocardiogram (ECG) screening may help to prevent cardiovascular disease (CVD) events, according to a study published online July 1 in JAMA...
View ArticleClik here to view.
Delaying Diabetes Progression After Impaired Glucose Improves Long-Term Outcomes
WEDNESDAY, July 10, 2024 (HealthDay News) — Maintaining several years of nondiabetes status after impaired glucose tolerance (IGT) diagnosis is associated with a significantly lower risk for poor...
View ArticleClik here to view.
Most Children With Conjunctivitis Have Rx for Topical Antibiotics Filled
WEDNESDAY, July 10, 2024 (HealthDay News) — More than two-thirds of children with conjunctivitis have a prescription filled for topical antibiotics within one day of an ambulatory care visit, according...
View ArticleClik here to view.
Case of Human Plague Confirmed in Colorado
WEDNESDAY, July 10, 2024 (HealthDay News) — Colorado health officials on Tuesday confirmed a case of human plague in that state. The infection — which occurred in Pueblo County, in the southern part of...
View ArticleClik here to view.
Second Recipient of Genetically Modified Pig Kidney Has Died
WEDNESDAY, July 10, 2024 (HealthDay News) — The second person to receive a kidney from a genetically modified pig has died, surgeons at NYU Langone Health announced Tuesday. The 54-year-old patient,...
View ArticleClik here to view.
Less Than Half of American Adults Know Dangers of Raw Milk
WEDNESDAY, July 10, 2024 (HealthDay News) — Few Americans understand the health risks of drinking raw milk, a new survey shows, so experts are redoubling efforts to get the word out on its dangers. The...
View ArticleMultiple Novel Oral Agents Show Promise in Psoriasis
Oral agents have show good efficacy results in patients with psoriasis. An oral agent is also easier for patients to intake then other forms of medication. Although biologics are known to offer high...
View ArticleSovleplenib Delivers Durable Responses and QOL Improvements in Primary Immune...
Sovleplenib may offer QOL improvements for patients with primary immune thrombocytopenia. Sovleplenib was associated with early and durable platelet responses in participants with primary immune...
View ArticleIs Pelabresib + Ruxolitinib the Paradigm-Shifting Combo Therapy for...
Pelabresib plus ruxolitinib has shown efficacy in the treatment responses of patients with myelofibrosis. Treatment with pelabresib plus ruxolitinib was associated with improvements in all four...
View ArticleRevumenib Displays Encouraging Anti-Tumor Activity in KMT2Ar Acute Leukemia,...
The AUGMENT-101 trial in patients with in KMT2Ar leukemia has been stopped early because of revumenib encouraging anti-tumor activity. In a heavily pretreated population of participants with KMT2A...
View ArticleQ&A: Flexibility With PrEP Highly Important for Gay, Bisexual and Queer Men
PrEP use among gay, bisexual, and queer men is dynamic, with no singular approach favored, and results warrant educational efforts on adaptable PrEP strategies. “HIV PrEP guidelines recommend both...
View ArticleClik here to view.
FDA Approves Zoryve for Atopic Dermatitis
THURSDAY, July 11, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult...
View ArticleClik here to view.
Globally, Loneliness Affects More Than One-Fifth of People
THURSDAY, July 11, 2024 (HealthDay News) — Loneliness strikes more than one in five people worldwide, with 23 percent saying they felt lonely “a lot of the previous day,” according to the results of a...
View ArticleClik here to view.
Tampons May Be a Source of Metal Exposure
THURSDAY, July 11, 2024 (HealthDay News) — Tampon use is a potential source of metal exposure, according to a study published in the August issue of Environmental International. Jenni A. Shearston,...
View Article